Companies · Healthtech

Pyx Health Holdings, Llc

TUCSON · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Pyx Health Holdings, Llc — recommendation, valuation, rhythm, risks.
$28.1M
Total raised · real
1
Rounds
Latest step-up
Top 16%
Sector rank · raised
Series B
Latest stage · inferred · Fri Jul 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Pyx Health Holdings, Llc looks over-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.58× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.0 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Pyx Health Holdings, Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
3.0 yr record
Peak capital year was 2023 with $28.1M across 1 filings.
Market position
ahead of 85% of Healthtech peers
Capital scale is ahead of 85% of Healthtech peers; modeled value is above 88% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2023: $28.1M across 1 filings.
  • Largest single filing was $28.1M on 2023-07-14.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Pyx Health Holdings, Llc is one of 2138 Healthtech companies tracked from TUCSON. By capital raised it ranks in the upper tier (ahead of 85% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
70
Investors (latest)
2023
Year incorporated
2023-07-14
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries B · 2023-07-14 Raised $28M (real) Modeled valuation $261M (est)$28M$261MSeries B2023

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$28.1M · 2023

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$260.8M
Base estimate est.
$66.0M
Conservative case
$561.8M
Upside case
$156.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
3.0 yr
Elapsed time used
3.0 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
3.0 yr
On record since
2023
First round
1
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.3× above median
This company$28.1M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.5× above median
This company$28.1M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 7.7× above median
This company$260.8M
Sector median$33.8M

Raised more than 85% of sector peers (real $). Modeled value above 88% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #23 of 98.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)Casana Care, Inc. · Series B Raised $56.4M · modeled $608.0M (est)Mendel Health Inc. · Series B Raised $52.7M · modeled $570.9M (est)Bicycle Health Inc. · Series B Raised $61.4M · modeled $492.6M (est)Brave Health, Inc. · Series B Raised $38.6M · modeled $485.7M (est)Flume Health, Inc. · Series B Raised $35.9M · modeled $446.0M (est)Healthy America, LLC · Series B Raised $31.0M · modeled $435.9M (est)Moxe Health Corp · Series B Raised $34.8M · modeled $404.2M (est)Kintsugi Mindful Wellness, Inc. · Series B Raised $25.0M · modeled $370.4M (est)Invoq Health, Inc. · Series B Raised $41.5M · modeled $362.5M (est)Folx Health, Inc. · Series B Raised $59.3M · modeled $355.7M (est)Recuro Health, Inc. · Series B Raised $44.2M · modeled $340.0M (est)Orchard Healthcare, Inc. · Series B Raised $34.8M · modeled $338.9M (est)Pyx Health Holdings, Llc (this company) Raised $28.1M · modeled $260.8M (est)Pyx Health Holdings, Llc
CompanyStageRaised · realValue · estvs peer med.
Casana Care, Inc.Series B$56.4M$608.0M3.68×
Mendel Health Inc.Series B$52.7M$570.9M3.45×
Bicycle Health Inc.Series B$61.4M$492.6M2.98×
Brave Health, Inc.Series B$38.6M$485.7M2.94×
Flume Health, Inc.Series B$35.9M$446.0M2.70×
Healthy America, LLCSeries B$31.0M$435.9M2.64×
Moxe Health CorpSeries B$34.8M$404.2M2.45×
Kintsugi Mindful Wellness, Inc.Series B$25.0M$370.4M2.24×
Invoq Health, Inc.Series B$41.5M$362.5M2.19×
Folx Health, Inc.Series B$59.3M$355.7M2.15×
Recuro Health, Inc.Series B$44.2M$340.0M2.06×
Orchard Healthcare, Inc.Series B$34.8M$338.9M2.05×
Pyx Health Holdings, Llc this companySeries B$28.1M$260.8M1.58×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$28.1M2023-07-14$156.1M$260.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$28.1M2023-07-14
    • First recorded raise — entered as Series B.
    • 70 investors on this round.
Intelligence
Modeled next raise
$44.9M
Modeled next size est.range $29.2M$71.9M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Dawn Owens3 other2023-07
ADAM LETSON2 other2023-07
CONOR GREEN2 other2023-07
CYNTHIA JORDAN2 other2023-07
DAN FISHER2 other2023-07
CAROL COLOMBO1 other2023-07
CHRISTINA RICE2023-07
Registry & provenance

Pyx Health Holdings, Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1986940
SEC CIK
2023
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Revel Health, LLCHealthtechSeries B$17.5M$433.2Mnetwork2 shared operators · same sector · same stage
Pyx Health, Inc.HealthtechSeries A$15.3M$207.2Mnetwork2 shared operators · same sector
Wildflower Health, Inc.HealthtechSeries B$19.6M$106.7Mnetwork1 shared operator · same sector · same stage
Real Time Medical Systems, LLCHealthtechSeries B$28.1M$367.9Msame sector · same stage
Tava Health, Inc.HealthtechSeries B$28.9M$129.6Msame sector · same stage
Calibrate Health NewCo, LLCHealthtechSeries B$29.1M$245.1Msame sector · same stage
Empassion Health Holdings, LlcHealthtechSeries B$26.9M$208.2Msame sector · same stage
Axena Health, Inc.HealthtechSeries B$26.8M$288.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Pyx Health, Inc.HealthtechSeries A$207.2M97%
PWN Health Holdings, Inc.HealthtechSeries C$1.5B86%
HealthChain Holdings LLCHealthtechPre-Seed$13.4M86%
Boston Health Economic Holdings, LLCHealthtechSeries C$1.6B85%
Pipeline Health Holdings LLCHealthtechSeries B$381.0M85%
GVC Health Technology Holdings Inc.HealthtechPre-Seed$10.9M85%
AMM Health Holdings, LLCHealthtechSeries A$187.0M85%
Prosper Health, Inc.HealthtechSeries B$93.5M85%
Frequently asked
How much funding has Pyx Health Holdings, Llc raised?
Pyx Health Holdings, Llc has raised approximately $28.1M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Pyx Health Holdings, Llc's estimated valuation?
Provath's modeled valuation for Pyx Health Holdings, Llc is approximately $260.8M (modeled range $66.0M–$561.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Pyx Health Holdings, Llc at?
Pyx Health Holdings, Llc's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Jul 14.
What does Pyx Health Holdings, Llc do and where is it based?
Pyx Health Holdings, Llc operates in the Healthtech sector, based in TUCSON.
Explore related

See where Pyx Health Holdings, Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Pyx Health Holdings, Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.